Stellate DNA
company
About
Stellate DNA develops proprietary DNA donor technology that is used to synthesize and produce single-strand DNA donors.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $256K
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Stellate DNA develops proprietary DNA donor technology that is used to synthesize and produce single-strand DNA donors. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$256K
Stellate DNA has raised a total of
$256K
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2021 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Stellate DNA is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
